We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.48B
AUM Growth
+$231M
Cap. Flow
-$87.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$29M
2
CNC icon
Centene
CNC
+$17.6M
3
KBR icon
KBR
KBR
+$16.5M
4
CDW icon
CDW
CDW
+$16.2M
5
IQV icon
IQVIA
IQV
+$16.1M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$27M
2
PVH icon
PVH
PVH
+$18.7M
3
TPR icon
Tapestry
TPR
+$18.2M
4
IART icon
Integra LifeSciences
IART
+$18.1M
5
MTZ icon
MasTec
MTZ
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 18%
3 Consumer Discretionary 12.44%
4 Industrials 12.24%
5 Energy 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPLK
76
DELISTED
Splunk Inc
SPLK
$15.2M 0.44%
125,899
+50,470
+67% +$5.59M
ANET icon
77
Arista Networks
ANET
$243B
$15.1M 0.43%
907,872
+892,992
+6,001% +$15.2M
TNDM icon
78
Tandem Diabetes Care
TNDM
$1.13B
$15.1M 0.43%
351,850
-103,320
-23% -$3.61M
SMTC icon
79
Semtech
SMTC
$14.1B
$15M 0.43%
270,050
-11,140
-4% -$582K
ITT icon
80
ITT
ITT
$17.7B
$14.7M 0.42%
240,240
+40,560
+20% +$2.34M
EVTC icon
81
Evertec
EVTC
$1.69B
$14.7M 0.42%
608,068
+44,438
+8% +$1.05M
POST icon
82
Post Holdings
POST
$3.5B
$14.6M 0.42%
+227,764
New +$14M
LPLA icon
83
LPL Financial
LPLA
$26.9B
$14.2M 0.41%
219,495
-22,575
-9% -$1.5M
EW icon
84
Edwards Lifesciences
EW
$49.4B
$14M 0.4%
240,750
-291,441
-55% -$14.3M
TXRH icon
85
Texas Roadhouse
TXRH
$11.1B
$13.9M 0.4%
200,125
-24,600
-11% -$1.67M
EVH icon
86
Evolent Health
EVH
$423M
$13.6M 0.39%
+479,360
New +$11.4M
BIIB icon
87
Biogen
BIIB
$31.9B
$13.4M 0.39%
38,065
+21,619
+131% +$7.44M
PLNT icon
88
Planet Fitness
PLNT
$3.84B
$13.4M 0.39%
248,691
-26,954
-10% -$1.34M
PENN icon
89
PENN Entertainment
PENN
$2.38B
$13.3M 0.38%
403,105
-17,155
-4% -$571K
SRPT icon
90
Sarepta Therapeutics
SRPT
$2.19B
$13.1M 0.38%
81,305
+11,835
+17% +$1.62M
TSLA icon
91
Tesla
TSLA
$1.41T
$13M 0.37%
735,810
-7,500
-1% -$156K
KRE icon
92
State Street SPDR S&P Regional Banking ETF
KRE
$4.31B
$12.9M 0.37%
216,300
– –
MIDD icon
93
Middleby
MIDD
$5.02B
$12.6M 0.36%
97,483
+64,275
+194% +$7.33M
NKE icon
94
Nike
NKE
$53.7B
$12.5M 0.36%
147,657
+145,657
+7,283% +$11.7M
RPD icon
95
Rapid7
RPD
$840M
$12.4M 0.36%
335,777
-5,210
-2% -$175K
FOXF icon
96
Fox Factory Holding Corp
FOXF
$805M
$12.2M 0.35%
+173,855
New +$10.6M
ISRG icon
97
Intuitive Surgical
ISRG
$133B
$12.2M 0.35%
63,540
– –
CBM
98
DELISTED
Cambrex Corporation
CBM
$12.1M 0.35%
+176,795
New +$10.9M
WPX
99
DELISTED
WPX Energy, Inc.
WPX
$11.8M 0.34%
588,505
+41,405
+8% +$767K
CLH icon
100
Clean Harbors
CLH
$16.8B
$11.8M 0.34%
+164,973
New +$10.5M
2 3
4
5 6

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q3 2018 Portfolio in Review

As of Q3 2018, Castleark Management held 433 positions worth $3.48B, up 7.1% from $3.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management's Q3 2018 filing shows 64 new, 81 increased, 104 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 289,654 shares worth $31.1M. The largest sale was Charles Schwab, an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Castleark Management's largest Q3 2018 buy was Eli Lilly: 289,654 shares worth $31.1M.
  • Castleark Management added most to CDW in Q3 2018, an estimated $16.2M increase.
  • Castleark Management's biggest Q3 2018 reduction was Charles Schwab, cutting an estimated $27M.
  • Castleark Management fully exited Tapestry in Q3 2018, selling an estimated $18.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.48B portfolio in Q3 2018.
  • Castleark Management opened 64 new positions and closed 64 in Q3 2018.
  • Castleark Management's portfolio value rose 7.1% quarter-over-quarter to $3.48B.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.